Please assess the completion status of the following clinical trial:

Trial Title: Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of acute myocardial infarction~* Vessel TIMI flow \< grade Ⅲ post-PCI~Exclusion Criteria:~* Heart failure of New York Heart Association (NYHA) class Ⅲ to class Ⅳ~* Sick sinus syndrome~* Atrioventricular block (grade Ⅱ and above)~* SBP ≤ 90mmHg or cardiogenic shock~* Heart Rate ≤60 bpm~* Pregnancy~* Renal or hepatic failure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- D (Type: EXPERIMENTAL): If no-reflow/slow-flow phenomenon was observed post-PCI, intracoronary infusion of diltiazem via an infusion microcatheter distal to the angioplasty site was performed.
- V (Type: ACTIVE_COMPARATOR): If no-reflow/slow-flow phenomenon was observed post-PCI, intracoronary infusion of verapamil via an infusion microcatheter distal to the angioplasty site was performed.
- N (Type: ACTIVE_COMPARATOR): If no-reflow/slow-flow phenomenon was observed post-PCI, intracoronary infusion of nitroglycerin via an infusion microcatheter distal to the angioplasty site was performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).